Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Chronic Myeloid Leukaemia

Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia

Abstract

We have analysed pre-transplant cytogenetic findings in 418 patients with CML in pre-blastic phase who underwent allogeneic BMT between February 1981 and January 1998. Five different patient groups were identified: A = Philadelphia (Ph)+; B = Ph−, BCR-ABL+; C = variant Ph (VPh); D = Ph chromosome plus at least one of: trisomy 8, +Ph, chromosome 17 abnormalities and E = other abnormalities in addition to the Ph chromosome. There were two principal conclusions. Firstly, Ph− patients showed a better outcome, and VPh patients a worse outcome, than those with a standard Ph, both in terms of leukaemia-free survival (LFS) (76.9%, 22.1% and 31.9%) and the risk of treatment failure relative to those with a standard Ph (relative risks of 0.49 and 1.92, respectively). One contributing factor may be relapse: no Ph− patients relapsed, whereas all other groups showed similar probabilities of relapse at 5 years (range 33.0–44.0%). Secondly, those with the additional changes of +8, +Ph and i(17q) did not show a worse outcome than those with no additional changes (5 year survival of 44.7% vs 51.8%; 5 year LFS of 40.6% vs 31.9%), whereas those with other additional changes may fare worst of all (40.4% and 16.0%, respectively). Bone Marrow Transplantation (2000) 25, 143–146.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Clift RA, Anasetti C . Allografting for chronic myeloid leukaemia Baillière's Clin Haematol 1997 10: 319–336

    Article  CAS  Google Scholar 

  2. Przepiorka D, Thomas ED . Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia Bone Marrow Transplant 1988 3: 113–119

    CAS  PubMed  Google Scholar 

  3. Slovak ML, Kopecky KJ, Wolman SR et al. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612) Leukemia Res 1995 19: 381–388

    Article  CAS  Google Scholar 

  4. Savage DG, Szydlo RM, Chase A et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining disease phase on probabilities of survival and relapse Br J Haematol 1997 99: 30–35

    Article  CAS  Google Scholar 

  5. Rooney DE, Czepulkowski BH (eds) . Human Cytogenetics: A Practical Approach v.II Oxford University Press: New York 1992

    Google Scholar 

  6. Webber L, Garson OM . Fluorodeoxyuridine synchronization of bone marrow cultures Cancer Genet Cytogenet 1983 8: 123–132

    Article  CAS  Google Scholar 

  7. ISCN An International System for Human Cytogenetics Nomenclature. Mitelman F (ed) S Karger: Basel 1995

  8. Kaplan EL, Meier P . Non parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  9. Gooley TA, Leisenrin W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stats Med 1999 18: 695–706

    Article  CAS  Google Scholar 

  10. Potter AM, Watmore AE, Cooke P et al. Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia Br J Cancer 1981 44: 51–54

    Article  CAS  Google Scholar 

  11. O'Brien S, Thall PF, Siciliano MJ . The cytogenetics of chronic myelogenous leukaemia Baillière's Clin Haematol 1997 10: 259–276

    Article  CAS  Google Scholar 

  12. Mitelman F . The cytogenetic scenario of chronic myeloid leukemia Leuk Lymphoma 1993 11: 11–15

    Article  Google Scholar 

  13. Popenoe DW, Schaefer-Rego K, Mears JG et al. Frequent and extensive deletion during the 9;22 translocation in CML Blood 1986 68: 1123–1128

    CAS  PubMed  Google Scholar 

  14. Sinclair, PB, Leversha M, Telford N et al. Chromosome 9 deletions accompany both standard and variant Ph translocations Br J Haematol 1998 101: (Suppl.1) 60 (Abstr.151)

    Google Scholar 

  15. Clift RA, Buckner CD, Thomas ED . Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia Blood 1994 84: 4368–4373

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Leukaemia Research Fund.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konstantinidou, P., Szydlo, R., Chase, A. et al. Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplant 25, 143–146 (2000). https://doi.org/10.1038/sj.bmt.1702133

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702133

Keywords

This article is cited by

Search

Quick links